Prognostic value of metabolic tumor volume measured by 18F- fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 115-122

  Hyun, Seung Hyup ^a   Choi, Joon Young ^a   Shim, Young Mog ^a   Kim, Kwhanmien ^a   Lee, Su Jin ^a   Cho, Young Seok ^a   Lee, Ji Young ^a   Lee, Kyung Han ^a   Kim, Byung Tae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC TUMOR VOLUME; METASTASIS; OVERALL SURVIVAL; PARAMETER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUBERCULOSIS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SEX; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 74649087061     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0719-7     Document Type: Article

References (28)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray, et al. 2008 Cancer statistics CA Cancer J Clin. 58 71 96 10.3322/CA.2007.0010 18287387
2. NP Rizk E Venkatraman MS Bains B Park R Flores L Tang, et al. 2007 American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma J Clin Oncol. 25 507 512 10.1200/JCO.2006.08.0101 17290058 (Pubitemid 350002956)
3. N Rizk E Venkatraman B Park R Flores MS Bains V Rusch 2006 The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system J Thorac Cardiovasc Surg. 132 1374 1381 10.1016/j.jtcvs.2006.07.039 17140960 (Pubitemid 44820247)
4. MA Eloubeidi R Desmond MR Arguedas CE Reed CM Wilcox 2002 Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status Cancer. 95 1434 1443 10.1002/cncr.10868 12237911
5. JY Choi HJ Jang YM Shim K Kim KS Lee KH Lee, et al. 2004 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications J Nucl Med. 45 1843 1850 15534053
6. JY Choi KT Jang YM Shim K Kim G Ahn KH Lee, et al. 2006 Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography Ann Surg Oncol. 13 1054 1062 10.1245/ASO.2006.08.012 16865594 (Pubitemid 44337964)
7. JY Choi KH Lee YM Shim KS Lee JJ Kim SE Kim, et al. 2000 Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET J Nucl Med. 41 808 815 1:STN:280:DC%2BD3c3mslWqsQ%3D%3D 10809196
8. D Hong S Lunagomez EE Kim JH Lee RS Bresalier SG Swisher, et al. 2005 Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma Cancer. 104 1620 1626 10.1002/cncr.21356 16118804 (Pubitemid 41437424)
9. TR Miller PW Grigsby 2002 Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int J Radiat Oncol Biol Phys. 53 353 359 12023139
10. MK Chen TH Chen JP Liu CC Chang WC Chie 2004 Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume Cancer. 100 2160 2166 10.1002/cncr.20210 15139059 (Pubitemid 38580335)
11. SK Mukherji IM Schmalfuss J Castelijns AA Mancuso 2004 Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract AJNR Am J Neuroradiol. 25 1425 1432 15466346
12. K Basaki Y Abe M Aoki H Kondo Y Hatayama S Nakaji 2006 Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume Int J Radiat Oncol Biol Phys. 64 449 454 16226400
13. P Lee DK Weerasuriya PW Lavori A Quon W Hara PG Maxim, et al. 2007 Metabolic tumor burden predicts for disease progression and death in lung cancer Int J Radiat Oncol Biol Phys. 69 328 333 17869659
14. M Werner-Wasik RS Swann J Bradley M Graham B Emami J Purdy, et al. 2008 Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 385 390 17869017
15. Greene FL. AJCC cancer staging manual. New York: Springer-Verlag; 2002.
16. X Zhong J Yu B Zhang D Mu W Zhang D Li, et al. 2009 Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys. 73 136 41 18538492
17. Y Zheng T Cai Z Feng 2006 Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers Biometrics 62 279 287 10.1111/j.1541-0420.2005.00441.x 16542256
18. PJ Heagerty T Lumley MS Pepe 2000 Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 56 337 344 10.1111/j.0006-341X. 2000.00337.x 1:STN:280:DC%2BD3cvotVyntw%3D%3D 10877287
19. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg. 82 391 394 10.1016/j.athoracsur.2006.03.045 16863735 discussion 4-5 (Pubitemid 44080040)
20. N Rizk RJ Downey T Akhurst M Gonen MS Bains S Larson, et al. 2006 Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection Ann Thorac Surg 81 1076 1081 10.1016/j.athoracsur.2005.09.063 16488726 (Pubitemid 43247692)
21. HL van Westreenen JT Plukker DC Cobben CJ Verhoogt H Groen PL Jager 2005 Prognostic value of the standardized uptake value in esophageal cancer AJR Am J Roentgenol 185 436 440 16037517
22. JM Omloo GW Sloof R Boellaard OS Hoekstra PL Jager HM van Dullemen, et al. 2008 Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer Endoscopy 40 464 471 10.1055/s-2008-1077302 1:STN:280:DC%2BD1cznsVKjsg%3D%3D 18543134 (Pubitemid 351911834)
23. M Soret SL Bacharach I Buvat 2007 Partial-volume effect in PET tumor imaging J Nucl Med 48 932 945 10.2967/jnumed.106.035774 17504879 (Pubitemid 46909922)
24. JB Roedl RR Colen NS Holalkere AJ Fischman NC Choi MA Blake 2008 Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation Radiother Oncol 89 278 286 10.1016/j.radonc.2008.06.014 1:CAS:528:DC%2BD1cXhsVCms73K 18701180
25. M Mamede ELP Abreu MR Oliva V Nose H Mamon VH Gerbaudo 2007 FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results Am J Clin Oncol 30 377 388 10.1097/COC.0b013e31803993f8 1:CAS:528:DC%2BD2sXhtVeiu7bI 17762438 (Pubitemid 47356682)
26. R Boellaard NC Krak OS Hoekstra AA Lammertsma 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med 45 1519 1527 15347719
27. JW Keyes Jr 1995 SUV: standard uptake or silly useless value? J Nucl Med 36 1836 1839 7562051
28. M Westerterp J Pruim W Oyen O Hoekstra A Paans E Visser, et al. 2007 Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters Eur J Nucl Med Mol Imaging 34 392 404 10.1007/s00259-006- 0224-1 17033848 (Pubitemid 46295349)